Announcements Trials
Browse Landscape

Phase

Phase 3 8Phase 4 4Phase 2 4Phase 1 4Phase NA 3Phase EARLY_PHASE1 1Phase 2/3 1

Status

Withdrawn 2Completed 2Unknown 1Terminated 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 7INDUSTRY 1

Study Type

Interventional 8

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Other 1Classical hematology 1Breast 1

Conditions

Neoplasms 3Pain, Intractable 2Cancer Pain 2Spinal Surgery 1Pain Related to Cancer 1Mucositis 1Leukemia 1Breast Neoplasms 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1Adenocarcinoma 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Methadone × Clear all
NCT05417100 2026-01-27

Understanding How Methadone Treatment During Surgery Affects Pain Levels and the Need for Pain Medications After Surgery

Memorial Sloan Kettering Cancer Center

Phase 3 Active not recruiting
17 enrolled

Spinal Surgery

NCT07092475 2025-11-26

The Impact of Intraoperative Methadone on Postoperative Opioid Use

University of Utah

Phase 3 Withdrawn
Breast

Breast Neoplasms

NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended
60 enrolled
Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

NCT01793480 2024-10-31

EQUIMETH2

RECORDATI GROUP

Phase 3 Completed
146 enrolled

Pain Related to Cancer

NCT05325164 2022-12-05

METHADOPT

Ottawa Hospital Research Institute

Phase 3 Withdrawn

Cancer Pain, Adenocarcinoma, Neoplasms

NCT02687347 2016-09-20

UDOME

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 3 Unknown
204 enrolled

Pain, Intractable

NCT00634010 2016-05-09

Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain

M.D. Anderson Cancer Center

Phase 3 Terminated
36 enrolled 6 charts

Cancer Pain

NCT00184496 2014-02-28

Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study

Norwegian University of Science and Technology

Phase 3 Completed
42 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡